MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Dysfluent Writing Behavior Associates with Reduced Striatal-cerebellar Connectivity in Writer’s Cramp Dystonia

    Z. Simsek, M. Lipp, S. Groves, Z. Huang, M. Fei, J. Voyvodic, C. Petty, M. Lutz, N. Bukhari-Parlakturk (Durham, USA)

    Objective: The primary objective of this study was to identify the brain regions contributing to dysfluent writing behavior in a subtype of dystonia called writer’s…
  • 2024 International Congress

    Beyond the Surface: Electromyography in Cervical Dystonia

    S. Lagerweij, M. van Egmond, M. Smit, L. Centen, M. van Dijk, JW. Elting, M. Tijssen (Groningen, Netherlands)

    Objective: To evaluate the presence of co-contractions and overflow in cervical dystonia (CD) patients and appraise the applicability of intermuscular coherence as an objective biomarker…
  • 2024 International Congress

    Amyloid Pathology and its association with Cognitive Status in Huntington’s Disease

    G. Olmedo Saura, J. Perez Perez, S. Martinez-Horta, A. Puig-Davi, A. Horta-Barba, A. Vazquez-Oliver, A. Campolongo, E. Rivas-Asensio, N. Salvat-Rovira, D. Alcolea, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To investigate the presence of beta-amyloid pathology in Huntington's disease (HD) and its potential impact on patients' cognitive status. Background: Recent evidence indicates that…
  • 2024 International Congress

    KMT2B-Related Dystonia And DBS: Tertiary Center Experience

    M. Alquaimi, H. Alfaris, A. Aldakheel, F. Alotaibi, S. Alqahtani, S. Boholega (Riyadh, Saudi Arabia)

    Objective: This study aims to evaluate the functional outcomes and effectiveness of deep brain stimulation (DBS) in patients with genetic dystonia secondary to a KMT2B …
  • 2024 International Congress

    Effect of bilateral internal segment of the globus pallidus deep brain stimulation on acquired multifocal dystonia due to natural gas intoxication.

    A. Luque-Ambrosiani, D. Macías-García, F. Carrillo, L. Muñoz-Delgado, S. Jesús, A. Adarmes-Gómez, E. Ojeda-Lepe, Y. Chocrón-González, M. Oliver-Romero, P. Mir (Seville, Spain)

    Objective: To communicate the effectiveness of internal globus pallidus deep brain stimulation (GPi-DBS) on a case of acquired dystonia due to natural gas intoxication. Background:…
  • 2024 International Congress

    Rapidly Progressive Pallidopyramidal Syndrome related to Parkin gene mutation

    F. Mustafa, A. Elavarasi, D. Vibha, R. Singh, J. Parihar, M. Tripathi, A. Das (Calicut, India)

    Objective: To describe a case of rapidly progressive Pallidopyramidal syndrome related to Parkin gene mutation. Background: Parkin gene mutations are most commonly found in autosomal…
  • 2024 International Congress

    Non-motor symptoms in people with Huntington’s disease: use and validation of the MDS Non-Motor Scale (MDS-NMS)

    JM. Valera-Bermejo, N. Martins, O. Makos, J. Badenoch, M. Hartmann, A. Rangel-Cristales, A. Rizos, K. Ray Chaudhuri, D. van Wamelen (London, United Kingdom)

    Objective: The primary objective of this project is to validate and personalise the existing MDS-NMS scale, originally developed for Parkinson’s disease, for use in people…
  • 2024 International Congress

    A Survey of Immunological Mechanisms in Cervical Dystonia

    L. Scorr, G. Kilic-Berkmen, J. Mckay, D. Sutcliffe, A. Mckeon, H. Jinnah (Atlanta, USA)

    Objective: The overall goal was to delineate which aspects of the immune system may be most relevant to the biology of CD. Background: Although several…
  • 2024 International Congress

    Serum urea and clinical outcomes in Huntington’s disease

    O. Makos, J. Badenoch, M. Hartmann, N. Martin, A. Rangel-Cristales, J. Valera-Bermejo, S. Williams, D. van Wamelen (London, United Kingdom)

    Objective: To investigate the relationship between serum urea levels and clinical outcomes in people with Huntington’s disease. Background: Several studies in people with Huntington’s disease…
  • 2024 International Congress

    Association between Morbidity and Social Vulnerability in Patients with Huntington Disease

    J. Patino, N. Rocha, S. Zadegan, B. Duncan, R. Ramphul, A. Sharrief, E. Furr Stimming (Houston, USA)

    Objective: To investigate how social vulnerability affects clinical outcomes in Huntington disease (HD) gene expansion carriers (HDGECs). Background: Social determinants of health (SDOH) are nonmedical…
  • « Previous Page
  • 1
  • …
  • 166
  • 167
  • 168
  • 169
  • 170
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • An atypical and interesting feature of Parkinson´s disease
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley